It is not surprising that mostly small to medium sized companies seek the help of specialist consultancies to find commercial partners or find in-licensing opportunities. Large pharma are in the attractive position that they get thousands of unsolicited licensing offers from small R&D companies every year and they have ample capacity to conduct due diligence on the promising candidates and partners. Their real concern is whether they can spot hidden gems from less commercially active research boutiques that do not actively search for partners early on before competition sees them. Additionally, large pharma regularly faces the issue of rejecting opportunities that their competition may pick up and in these situations the inevitable internal questions arise from senior executives about the effectiveness of the internal evaluation capabilities.

Finding and Executing Pharma Licensing Opportunities

Download Request